[1]
“EVALUATION OF PHARMACOTHERAPEUTIC FOLLOW-UP OF THE USE OF TUBERCULOSTATS IN PATIENTS INTERNED IN AN INFECTOLOGY HOSPITAL IN THE AMAZON”, RECIMA21, vol. 5, no. 5, p. e555278, May 2024, doi: 10.47820/recima21.v5i5.5278.